Critical Reviews in Therapeutic Drug Carrier Systems
Last updated ISSN 0743-4863
Critical Reviews in Therapeutic Drug Carrier Systems is published by Begell House in pharmacology, toxicology and pharmaceutics. It is a subscription journal. Its article processing charge is not published.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Critical Reviews in Therapeutic Drug Carrier Systems is — and show you journals like it.
What it publishes
Recent work in Critical Reviews in Therapeutic Drug Carrier Systems concentrates on these topics, taken from its published record rather than from its own description:
- Advanced Drug Delivery Systems
- Nanoparticle-Based Drug Delivery
- Drug Solubulity and Delivery Systems
- RNA Interference and Gene Delivery
- Advancements in Transdermal Drug Delivery
- Advanced biosensing and bioanalysis techniques
- Lipid Membrane Structure and Behavior
- Inhalation and Respiratory Drug Delivery
- Innovative Microfluidic and Catalytic Techniques Innovation
- Computational Drug Discovery Methods
Key facts
| Publisher | Begell House |
|---|---|
| ISSN | 0743-4863, 2162-660X |
| Subject area | Pharmacology, Toxicology and Pharmaceutics |
| Access | Subscription |
| Article processing charge | Not published |
| Indexed in | Web of Science — Science Citation Index Expanded · Scopus |
| Articles published | 619 |
| Publishing since | 1987 |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Critical Reviews in Therapeutic Drug Carrier Systems
Other established journals in pharmacology, toxicology and pharmaceutics, if this one is not the right home for your paper: